K23 AR051125/AR/NIAMS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2004	1
2005	2
2006	2
2008	6
2009	7
2010	5
2011	1
2022	0

1

Psoriasis and metabolic disease: epidemiology and pathophysiology.

Azfar RS, Gelfand JM. Azfar RS, et al. Curr Opin Rheumatol. 2008 Jul;20(4):416-22. doi: 10.1097/BOR.0b013e3283031c99. Curr Opin Rheumatol. 2008. PMID: 18525354 Free PMC article. Review.

2

Update on the natural history and systemic treatment of psoriasis.

Richardson SK, Gelfand JM. Richardson SK, et al. Adv Dermatol. 2008;24:171-96. doi: 10.1016/j.yadr.2008.09.006. Adv Dermatol. 2008. PMID: 19256309 Free PMC article. Review.

3

Is there truly a risk of lymphoma from biologic therapies?

Dommasch E, Gelfand JM. Dommasch E, et al. Dermatol Ther. 2009 Sep-Oct;22(5):418-30. doi: 10.1111/j.1529-8019.2009.01258.x. Dermatol Ther. 2009. PMID: 19845719 Free PMC article. Review.

4

Assessing long-term drug safety: lessons (re) learned from raptiva.

Seminara NM, Gelfand JM. Seminara NM, et al. Semin Cutan Med Surg. 2010 Mar;29(1):16-9. doi: 10.1016/j.sder.2010.01.001. Semin Cutan Med Surg. 2010. PMID: 20430303 Free PMC article. Review.

5

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, Korman NJ, Korver G, Krueger GG, Strober BE, Lebwohl MG; National Psoriasis Foundation. Kimball AB, et al. J Am Acad Dermatol. 2008 Jun;58(6):1031-42. doi: 10.1016/j.jaad.2008.01.006. Epub 2008 Mar 4. J Am Acad Dermatol. 2008. PMID: 18313171 Free PMC article. Review.

6

The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials.

Dommasch ED, Abuabara K, Shin DB, Nguyen J, Troxel AB, Gelfand JM. Dommasch ED, et al. J Am Acad Dermatol. 2011 Jun;64(6):1035-50. doi: 10.1016/j.jaad.2010.09.734. Epub 2011 Feb 18. J Am Acad Dermatol. 2011. PMID: 21315483 Free PMC article. Review.

7

The prevalence of psoriasis in African Americans: results from a population-based study.

Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, Rolstad T, Margolis DJ. Gelfand JM, et al. J Am Acad Dermatol. 2005 Jan;52(1):23-6. doi: 10.1016/j.jaad.2004.07.045. J Am Acad Dermatol. 2005. PMID: 15627076

8

Epidemiology of psoriatic arthritis in the population of the United States.

Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Gelfand JM, et al. J Am Acad Dermatol. 2005 Oct;53(4):573. doi: 10.1016/j.jaad.2005.03.046. J Am Acad Dermatol. 2005. PMID: 16198775

9

The risk of stroke in patients with psoriasis.

Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB. Gelfand JM, et al. J Invest Dermatol. 2009 Oct;129(10):2411-8. doi: 10.1038/jid.2009.112. Epub 2009 May 21. J Invest Dermatol. 2009. PMID: 19458634 Free PMC article.

10

Risk of myocardial infarction in patients with psoriasis.

Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Gelfand JM, et al. JAMA. 2006 Oct 11;296(14):1735-41. doi: 10.1001/jama.296.14.1735. JAMA. 2006. PMID: 17032986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results